This document outlines details of PBS-subsidised avatrombopag, eltrombopag and romiplostim for patients with severe chronic immune (idiopathic) thrombocytopenic purpura (ITP).
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.
Idiopathic thrombocytopenic purpura (ITP) quick reference
|
Restrictions |
Authority level and section |
PA assessment |
Processing system |
Prescriber type |
Prescriber
self-serve |
|
Initial
PB097 form |
Written
Electronic
S100:
avatrombopag
eltrombopag
romiplostim
|
No |
OPA
|
Not specified |
Yes |
|
First continuing or re-initiation of interrupted continuing treatment
|
Telephone
Electronic
S100:
avatrombopag
eltrombopag
romiplostim
|
No |
OPA
|
Not specified |
Yes |
|
Second or subsequent continuing |
Telephone
Electronic
S100:
avatrombopag
eltrombopag
romiplostim
|
No |
OPA
|
Not specified |
Yes |
|
Balance of supply or change of therapy
|
Telephone
Electronic
S100:
avatrombopag
eltrombopag
romiplostim
|
No |
OPA
|
Not specified |
Yes |
Expand all